Cardiff Oncology Statistics
Total Valuation
CRDF has a market cap or net worth of $281.07 million. The enterprise value is $147.93 million.
Important Dates
The next estimated earnings date is Thursday, May 1, 2025, after market close.
| Earnings Date | May 1, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
CRDF has 66.52 million shares outstanding. The number of shares has increased by 6.65% in one year.
| Current Share Class | 66.52M |
| Shares Outstanding | 66.52M |
| Shares Change (YoY) | +6.65% |
| Shares Change (QoQ) | +15.69% |
| Owned by Insiders (%) | 2.02% |
| Owned by Institutions (%) | 34.27% |
| Float | 59.80M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 249.77 |
| Forward PS | 581.28 |
| PB Ratio | 2.87 |
| P/TBV Ratio | 2.87 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 216.59 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 7.08, with a Debt / Equity ratio of 0.02.
| Current Ratio | 7.08 |
| Quick Ratio | 6.92 |
| Debt / Equity | 0.02 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -59.51% and return on invested capital (ROIC) is -38.89%.
| Return on Equity (ROE) | -59.51% |
| Return on Assets (ROA) | -34.01% |
| Return on Invested Capital (ROIC) | -38.89% |
| Return on Capital Employed (ROCE) | -58.08% |
| Revenue Per Employee | $20,697 |
| Profits Per Employee | -$1.38M |
| Employee Count | 33 |
| Asset Turnover | 0.01 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +2.72% in the last 52 weeks. The beta is 1.73, so CRDF's price volatility has been higher than the market average.
| Beta (5Y) | 1.73 |
| 52-Week Price Change | +2.72% |
| 50-Day Moving Average | 4.04 |
| 200-Day Moving Average | 3.06 |
| Relative Strength Index (RSI) | 51.26 |
| Average Volume (20 Days) | 1,066,595 |
Short Selling Information
The latest short interest is 10.84 million, so 16.30% of the outstanding shares have been sold short.
| Short Interest | 10.84M |
| Short Previous Month | 10.45M |
| Short % of Shares Out | 16.30% |
| Short % of Float | 18.13% |
| Short Ratio (days to cover) | 11.73 |
Income Statement
In the last 12 months, CRDF had revenue of $683,000 and -$45.46 million in losses. Loss per share was -$0.95.
| Revenue | 683,000 |
| Gross Profit | -36.17M |
| Operating Income | -48.65M |
| Pretax Income | -40.86M |
| Net Income | -45.46M |
| EBITDA | -48.25M |
| EBIT | -48.65M |
| Loss Per Share | -$0.95 |
Full Income StatementBalance Sheet
The company has $91.75 million in cash and $1.52 million in debt, giving a net cash position of $90.22 million or $1.36 per share.
| Cash & Cash Equivalents | 91.75M |
| Total Debt | 1.52M |
| Net Cash | 90.22M |
| Net Cash Per Share | $1.36 |
| Equity (Book Value) | 82.95M |
| Book Value Per Share | 1.25 |
| Working Capital | 81.63M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$37.69 million and capital expenditures -$80,000, giving a free cash flow of -$37.77 million.
| Operating Cash Flow | -37.69M |
| Capital Expenditures | -80,000 |
| Free Cash Flow | -37.77M |
| FCF Per Share | -$0.57 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | -7,123.13% |
| Pretax Margin | -6,651.68% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
CRDF does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -6.65% |
| Shareholder Yield | n/a |
| Earnings Yield | -19.09% |
| FCF Yield | -15.86% |
Analyst Forecast
The average price target for CRDF is $12.00, which is 184.02% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $12.00 |
| Price Target Difference | 184.02% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 4 |
| Revenue Growth Forecast (5Y) | 181.52% |
| EPS Growth Forecast (5Y) | 7.46% |
Stock ForecastsStock Splits
The last stock split was on February 20, 2019. It was a reverse split with a ratio of 0.1666666:1.
| Last Split Date | Feb 20, 2019 |
| Split Type | Reverse |
| Split Ratio | 0.1666666:1 |
Scores
CRDF has an Altman Z-Score of -0.23 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -0.23 |
| Piotroski F-Score | 3 |